Author

Shelly Kaushik

Observed name: Kaushik, Shelly

Institution: ORIC Pharmaceuticals, Inc. (United States)

Observed institutions: National University of Singapore, University of California, San Francisco, ORIC Pharmaceuticals, Inc. (United States), Mechanobiology Institute

ORCID: 0000-0002-8967-3265

Observed ORCID: 0000-0002-8967-3265

OpenAlex ID: A5077999999

From transformation to metastasis: deconstructing the extracellular matrix in breast cancer

2016 · Shelly Kaushik, Michael W Pickup, et al. · Cancer and Metastasis Reviews · 167

A tension-mediated glycocalyx–integrin feedback loop promotes mesenchymal-like glioblastoma

2018 · J. Matthew Barnes, Shelly Kaushik, et al. · Nature Cell Biology · 160

Tissue mechanics, an important regulator of development and disease

2019 · Nadia M. E. Ayad, Shelly Kaushik, et al. · Philosophical Transactions of the Royal Society B Biological Sciences · 89

Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype

2015 · Yamicia Connor, Sarah Tekleab, et al. · Nature Communications · 85

PDF

Development of a facile antibody–drug conjugate platform for increased stability and homogeneity

2016 · Nimish Gupta, Johny Kancharla, et al. · Chemical Science · 40

PDF

Concerted modulation of paxillin dynamics at focal adhesions by deleted in liver cancer‐1 and focal adhesion kinase during early cell spreading

2014 · Shelly Kaushik, Archna Ravi, et al. · Cytoskeleton · 29

Epidermal Growth Factor Activates the Rho GTPase-activating Protein (GAP) Deleted in Liver Cancer 1 via Focal Adhesion Kinase and Protein Phosphatase 2A

2014 · Archna Ravi, Shelly Kaushik, et al. · Journal of Biological Chemistry · 27

PDF

Unlocking the Dangers of a Stiffening Brain

2018 · Shelly Kaushik, Anders I. Persson · Neuron · 6

PDF

Abstract 1131: ORIC-944, a potent and selective allosteric PRC2 inhibitor, demonstrates robust in vivo activity in prostate cancer models

2021 · Anneleen Daemen, Jessica D. Sun, et al. · Cancer Research · 3

Abstract 1900: A tension-mediated glycocalyx feedback loop promotes glioblastoma

2019 · Shelly Kaushik, James Matthew Barnes, et al. · Cancer Research · 1

Abstract 649: Supramolecular assembly of antibody-drug conjugates using CORDLink platform for targeted drug delivery

2015 · Nimish Gupta, Johny Kancharla, et al. · Cancer Research · 1

Abstract 2791: Biomarker strategy for a phase 1 study of ORIC-944, a potent and selective allosteric PRC2 inhibitor, in patients with metastatic prostate cancer

2023 · Anneleen Daemen, Natalie Yuen, et al. · Cancer Research

Abstract 1900: A tension-mediated glycocalyx feedback loop promotes glioblastoma

2019 · Shelly Kaushik, James Matthew Barnes, et al. · Tumor Biology

Peer Review Report For: Usefulness of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as a predictor of disease-free survival in breast cancer: A cross-sectional study [version 1; peer review: 1 approved with reservations, 1 not approved]

2019 · Kaushik, Shelly, Dhruv Thakar · F1000Research

PDF

Tmic-43. a Tension-mediated Glycocalyx Feedback Loop Promotes a Mesenchymal, Stem-like Phenotype in Glioblastoma

2018 · Shelly Kaushik, James Matthew Barnes, et al. · Neuro-Oncology

PDF

Abstract 3985: NCoR2 regulates glioblastoma progression and treatment resistance

2017 · Shelly Kaushik, Joanna J. Phillips, et al. · Cancer Research

Abstract 2231: IO125 is a potent inducer of tumor immunogenicity

2016 · Sanghamitra Mylavarapu, Shelly Kaushik, et al. · Cancer Research

Role of DLC1 in Regulating Cellular and Focal Adhesion Dynamics

2013 · Shelly Kaushik, Boon Chuan Low · The FASEB Journal

Works count: 18

Citation count: 608

H-index: 7

I10-index: 7